·07/05/08 Gla glances at proteins
·07/05/08 The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
·07/05/08 After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
·07/05/08 The role of CCL21 in recruitment of T-precursor cells to fetal thymi
·07/05/08 Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient
·07/05/08 Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative
·07/05/08 Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412
·07/05/08 Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB
·07/05/08 Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants
·07/05/08 Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity
·07/05/08 Enforced expression of an Flt3 internal tandem duplication in human CD34+ cells confers properties of self-renewal and enhanced erythropoiesis
·07/05/08 CLL d: progress at last!
·07/05/08 Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors
·07/05/08 Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene–targeted mice
·07/05/08 Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo
·07/05/08 Modulation of hematopoietic and endothelial cell differentiation from mouse embryonic stem cells by different culture conditions
·07/05/08 Nongenomic effects of 17-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor and Src kinase
·07/05/08 The -carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding
·07/05/08 Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia
·07/05/08 A Fli in the ointment
·07/05/08 Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin
·07/05/08 Clotting hits the wall
·07/05/08 Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol
·07/05/08 Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells
·07/05/08 Rod mutations associated with MYH9-related disorders disrupt nonmuscle myosin-IIA assembly
·07/05/08 LDL-receptor–related protein regulates 2-integrin–mediated leukocyte adhesion
·07/05/08 Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cells
·07/05/08 Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen
·07/05/08 Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall
·07/05/08 Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction
·07/05/08 Platelet-associated CD154 in immune thrombocytopenic purpura
·07/05/08 Impaired CD40L signaling is a cause of defective IL-12 and TNF- production in Sezary syndrome: circumvention by hexameric soluble CD40L
·07/05/08 New insights in heparin-induced thrombocytopenia
·07/05/08 Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl)
·07/05/08 NKG2D receptor–mediated NK cell function is regulated by inhibitory Ly49 receptors

1 [2] [下一页] [尾页]